These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The use of human chorionic gonadotropin in recurrent abortion. Sandler SW; Baillie P S Afr Med J; 1979 May; 55(21):832-5. PubMed ID: 472911 [TBL] [Abstract][Full Text] [Related]
24. [THEORETICAL CHARACTERISTICS OF CHORIONIC GONADOTROPIN THERAPY AND ITS USE IN THREATENED ABORTION]. NYIRI I; TAKACS I Zentralbl Gynakol; 1964 Jul; 86():990-7. PubMed ID: 14253030 [No Abstract] [Full Text] [Related]
25. [Human chorionic gonadotropin (HCG) excretion in the urine in habitual threatened abortion treated with gestanon]. Wawryk R; Samochowiec E; Rzempoluch J; Pilarz E Ginekol Pol; 1973 Jun; 44(6):665-70. PubMed ID: 4720463 [No Abstract] [Full Text] [Related]
26. Evaluation of the outcome of pregnancy in threatened abortion by biochemical methods. Karjalainen O; Stenman U; Wichmann K; Widholm O Ann Chir Gynaecol Fenn; 1974; 63(6):457-64. PubMed ID: 4140705 [TBL] [Abstract][Full Text] [Related]
27. [Content of chorionic gonadotropins in urine of women with threatened abortion]. Berko AT Pediatr Akus Ginekol; 1971; 1():37-40. PubMed ID: 5092099 [No Abstract] [Full Text] [Related]
28. Alpha-fetoprotein: a marker for threatened abortion. Sande HA; Fagerhol M; Molnar O; Foss OP; Torjesen P Int J Gynaecol Obstet; 1978-1979; 16(4):293-5. PubMed ID: 86467 [TBL] [Abstract][Full Text] [Related]
29. Human placental lactogen as an index of placental function. Zuckerman H; Gendler L; Schwarz M; Harpaz S Isr J Med Sci; 1974 May; 10(5):490-4. PubMed ID: 4413719 [No Abstract] [Full Text] [Related]
30. [Effects of laser-puncture therapy in threatened abortion on the hormone content of the blood]. Dzhvebenava GG; Bakradze MM; Kepuladze MP; Abuladze MV Akush Ginekol (Mosk); 1983 Dec; (12):32-3. PubMed ID: 6666817 [No Abstract] [Full Text] [Related]
31. [Practical screening for the dysfunctional feto-placental unit during pregnancy (author's transl)]. Honda T Nihon Naibunpi Gakkai Zasshi; 1978 Oct; 54(10):1125-50. PubMed ID: 720693 [No Abstract] [Full Text] [Related]
32. [Vaginal cytology and urinary pregnanediol levels in threatened abortion, actual abortion and missed abortion]. Pannain A Arch Ostet Ginecol; 1969; 74(1):14-49. PubMed ID: 5404584 [No Abstract] [Full Text] [Related]
33. [Use of central electroanalgesia for treating threatened abortions]. Bashmakova NV Vopr Okhr Materin Det; 1980 Feb; 25(2):54-6. PubMed ID: 7368646 [No Abstract] [Full Text] [Related]
34. Value of HCG and HCS measurement in clinical practice. Crosignani PG; Trojsi L; Attanasio AE; Finzi GC Obstet Gynecol; 1974 Nov; 44(5):673-81. PubMed ID: 4213790 [No Abstract] [Full Text] [Related]
35. Human placental lactogen (HPL) in serum in complicated early pregnancy. Ylikorkala O; Jouppila P J Obstet Gynaecol Br Commonw; 1973 Dec; 80(12):1040-5. PubMed ID: 4761378 [No Abstract] [Full Text] [Related]
36. The prognostic value of human placental lactogen levels in threatened abortion in general practice. Gau DW; Gau G J R Coll Gen Pract; 1977 Feb; 27(175):91-2. PubMed ID: 845855 [TBL] [Abstract][Full Text] [Related]
39. [Hormone content in the plasma of women with threatened abortion treated by acupuncture]. Vorontsova GM; Malysheva VA Akush Ginekol (Mosk); 1981 May; (5):19-20. PubMed ID: 7294299 [No Abstract] [Full Text] [Related]
40. [Diagnostic and prognostic significance of hormone determination in the 1st half of pregnancy]. Runnebaum B; Gerhard I Gynakologe; 1983 Sep; 16(3):155-72. PubMed ID: 6196261 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]